check_circleStudy Completed

Diagnostic imaging

Bayer Identifier:

Trial_88058

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Contrast quality and tolerance of Iotrolan 300 in the diagnosis of the upper gastro intestinal tract of babies and infants

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

1 - 3 Years
  • -

  • -

Trial summary

Enrollment Goal
118
Trial Dates
April 1988 - May 1989
Phase
Phase 4
Could I Receive a placebo
N/A
Products
Isovist (Iotrolan, BAY86-4879)
Accepts Healthy Volunteer
N/A

Trial design

Contrast quality and tolerance of Iotrolan 300 in the diagnosis of the upper gastro intestinal tract of babies and infants
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.